These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19301416)

  • 1. Positron emission tomography imaging of D(2/3) agonist binding in healthy human subjects with the radiotracer [(11)C]-N-propyl-norapomorphine: preliminary evaluation and reproducibility studies.
    Narendran R; Frankle WG; Mason NS; Laymon CM; Lopresti BJ; Price JC; Kendro S; Vora S; Litschge M; Mountz JM; Mathis CA
    Synapse; 2009 Jul; 63(7):574-84. PubMed ID: 19301416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of dopamine D2/3 agonist binding in cocaine dependence: a [11C]NPA positron emission tomography study.
    Narendran R; Martinez D; Mason NS; Lopresti BJ; Himes ML; Chen CM; May MA; Price JC; Mathis CA; Frankle WG
    Synapse; 2011 Dec; 65(12):1344-9. PubMed ID: 21780185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine release.
    Narendran R; Mason NS; Chen CM; Himes M; Keating P; May MA; Rabiner EA; Laruelle M; Mathis CA; Frankle WG
    Synapse; 2011 Oct; 65(10):991-7. PubMed ID: 21360596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of (-)-N-(11)C-propyl-norapomorphine in vivo binding in nonhuman primates.
    Hwang DR; Narendran R; Huang Y; Slifstein M; Talbot PS; Sudo Y; Van Berckel BN; Kegeles LS; Martinez D; Laruelle M
    J Nucl Med; 2004 Feb; 45(2):338-46. PubMed ID: 14960658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parametric Imaging and Test-Retest Variability of ¹¹C-(+)-PHNO Binding to D₂/D₃ Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner.
    Gallezot JD; Zheng MQ; Lim K; Lin SF; Labaree D; Matuskey D; Huang Y; Ding YS; Carson RE; Malison RT
    J Nucl Med; 2014 Jun; 55(6):960-6. PubMed ID: 24732151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoflurane anaesthesia differentially affects the amphetamine sensitivity of agonist and antagonist D2/D3 positron emission tomography radiotracers: implications for in vivo imaging of dopamine release.
    McCormick PN; Ginovart N; Wilson AA
    Mol Imaging Biol; 2011 Aug; 13(4):737-46. PubMed ID: 20680481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography imaging of dopamine D₂/₃ receptors in the human cortex with [¹¹C]FLB 457: reproducibility studies.
    Narendran R; Mason NS; May MA; Chen CM; Kendro S; Ridler K; Rabiner EA; Laruelle M; Mathis CA; Frankle WG
    Synapse; 2011 Jan; 65(1):35-40. PubMed ID: 20506186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatum.
    Narendran R; Mason NS; Laymon CM; Lopresti BJ; Velasquez ND; May MA; Kendro S; Martinez D; Mathis CA; Frankle WG
    J Pharmacol Exp Ther; 2010 May; 333(2):533-9. PubMed ID: 20103586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-in-Human Assessment of
    Naganawa M; Nabulsi N; Henry S; Matuskey D; Lin SF; Slieker L; Schwarz AJ; Kant N; Jesudason C; Ruley K; Navarro A; Gao H; Ropchan J; Labaree D; Carson RE; Huang Y
    J Nucl Med; 2021 Apr; 62(4):553-560. PubMed ID: 32859711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-N-[(11)C]propyl-norapomorphine: a positron-labeled dopamine agonist for PET imaging of D(2) receptors.
    Hwang DR; Kegeles LS; Laruelle M
    Nucl Med Biol; 2000 Aug; 27(6):533-9. PubMed ID: 11056366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of post-amphetamine [11C]FLB 457 binding to cortical D2/3 receptors.
    Narendran R; Himes M; Mason NS
    PLoS One; 2013; 8(9):e76905. PubMed ID: 24098812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia.
    Frankle WG; Paris J; Himes M; Mason NS; Mathis CA; Narendran R
    Biol Psychiatry; 2018 Apr; 83(8):707-714. PubMed ID: 29325847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between striatal subregions and extrastriatal regions in dopamine D(1) receptor expression: a positron emission tomography study.
    Fujiwara H; Ito H; Kodaka F; Kimura Y; Takano H; Suhara T
    PLoS One; 2012; 7(11):e49775. PubMed ID: 23185434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Preliminary Investigation of the Effect of Acute Alcohol on Dopamine Transmission as Assessed by [
    Thiruchselvam T; Wilson AA; Boileau I; Le Foll B
    Alcohol Clin Exp Res; 2017 Jun; 41(6):1112-1119. PubMed ID: 28421623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic Modeling and Test-Retest Reproducibility of
    Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
    J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility.
    Abi-Dargham A; Martinez D; Mawlawi O; Simpson N; Hwang DR; Slifstein M; Anjilvel S; Pidcock J; Guo NN; Lombardo I; Mann JJ; Van Heertum R; Foged C; Halldin C; Laruelle M
    J Cereb Blood Flow Metab; 2000 Feb; 20(2):225-43. PubMed ID: 10698059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography.
    Kegeles LS; Slifstein M; Xu X; Urban N; Thompson JL; Moadel T; Harkavy-Friedman JM; Gil R; Laruelle M; Abi-Dargham A
    Biol Psychiatry; 2010 Oct; 68(7):634-41. PubMed ID: 20673873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study.
    Finnema SJ; Stepanov V; Nakao R; Sromek AW; Zhang T; Neumeyer JL; George SR; Seeman P; Stabin MG; Jonsson C; Farde L; Halldin C
    J Nucl Med; 2014 Jul; 55(7):1164-70. PubMed ID: 24790219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.